SEC Filing: Mylan - Update on EC generics investigation
MLex Summary: Mylan has stated that it received noticed from the commission on 6 October regarding a possible infringement of competition rules by it and its affiliates. It is co-operating with...To view the full article, register now.
Already a subscriber? Click here to view full article